Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Clayton

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Veterinary Record|September 13, 2011
Reorganisation of laboratory services at AHVLA centresPaul Roger, Matt Colston, Anne Gibbs, et al.
Journal of Orofacial Pain|July 30, 2009
Changes in proteinase-activated receptor 2 expression in the human tooth pulp in relation to caries and painClaire R Morgan, Helen D Rodd, Nick Clayton, et al.
Journal of Orofacial Pain|August 19, 2005
Vanilloid receptor 1 expression in human tooth pulp in relation to caries and painClaire R Morgan, Helen D Rodd, Nick Clayton, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitizationSharon Bingham, Paul J Beswick, Chas Bountra, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Veterinary Record|September 13, 2011
Reorganisation of laboratory services at AHVLA centresPaul Roger, Matt Colston, Anne Gibbs, et al.
Journal of Orofacial Pain|July 30, 2009
Changes in proteinase-activated receptor 2 expression in the human tooth pulp in relation to caries and painClaire R Morgan, Helen D Rodd, Nick Clayton, et al.
Journal of Orofacial Pain|August 19, 2005
Vanilloid receptor 1 expression in human tooth pulp in relation to caries and painClaire R Morgan, Helen D Rodd, Nick Clayton, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitizationSharon Bingham, Paul J Beswick, Chas Bountra, et al.
Pageof 2